VEGFA and cancer: Particularly, several studies have demonstrated that low-dose PTX has anti-angiogenesis effects and that it can depress the product of vascular endothelial growth factor (VEGF) [20] and hypoxia-inducible factor-α (HIF-α) [21] in cancer.